ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Condition(s) studied
Investigational drug(s) / intervention(s)
Aspirin: Patients will take aspirin 100 mg/day.
High-intensity statin: Statin intensity is defined according to the 2026 ACC/AHA Guideline on the Management of Dyslipidemia
Guideline-directed statin therapy: Statin intensity is defined according to the 2026 ACC/AHA Guideline on the Management of Dyslipidemia
Study summary
The primary objective of the ASA-3C trial is to evaluate the role of aspirin and high-intensity statin therapy, respectively, in individuals with severe coronary calcification (coronary calcium score ≥300) to prevent atherosclerotic cardiovascular disease (ASCVD) events with severe coronary calcification (CAC ≥300).
Eligibility
Primary outcome measure(s)
- Event rate of a composite of atherosclerotic cardiovascular disease event — 3 years
cardiovascular death; myocardial infarction ; hospitalization for Acute coronary syndrome; stroke; Transient ischaemic attack; peripheral arterial ischemia ;revascularization of coronary, carotid, or peripheral artery ;or death from an undetermined cause
Trial sites (32)
| Facility | City | Region | Status |
|---|---|---|---|
| Hallym University Medical Center | Anyang | South Korea | Not Yet Recruiting |
| SAM hospital | Anyang | South Korea | Not Yet Recruiting |
| Sejong General Hospital | Bucheon-si | South Korea | Recruiting |
| Dong-A University Hospital | Busan | South Korea | Not Yet Recruiting |
| Haeundae paik hospital, inje university | Busan | South Korea | Recruiting |
| Inje University Busan Paik Hospital | Busan | South Korea | Recruiting |
| Gyeongsang National University Changwon Hospital | Changwon | South Korea | Recruiting |
| Chungbuk National University Hospital | Cheonju | South Korea | Recruiting |
| Hallym University Chuncheon Sacred Heart Hospital | Chuncheon | South Korea | Not Yet Recruiting |
| Kangwon National University Hospital | Chuncheon | South Korea | Recruiting |
| Keimyung University Dongsan Medical Center | Daegu | South Korea | Recruiting |
| Kyungpook National University Hospital | Daegu | South Korea | Recruiting |
| Yeungnam University Medical Center | Daegu | South Korea | Not Yet Recruiting |
| Chungnam National University Hospital | Daejeon | South Korea | Recruiting |
| The Catholic University of Korea, Daejeon St. Mary's Hosptial | Daejeon | South Korea | Recruiting |
| GangNeung Asan Hospital | Gangneung | South Korea | Recruiting |
| Chonnam National University Hospital | Gwangju | South Korea | Recruiting |
| Incheon St. Mary's Hospital, The Catholic University of Korea | Incheon | South Korea | Not Yet Recruiting |
| Jeonbuk National University Hospital | Jeonju | South Korea | Recruiting |
| Kwangju Christian Hospital | Kwangju | South Korea | Not Yet Recruiting |
| Asan Medical Center | Seoul | South Korea | Recruiting |
| Hanil General Hospital | Seoul | South Korea | Recruiting |
| Hanyang University Seoul Hospital | Seoul | South Korea | Recruiting |
| Kangbuk Samsung Hospital | Seoul | South Korea | Not Yet Recruiting |
| Korea University Guro Hospital | Seoul | South Korea | Recruiting |
| Severance Hospital | Seoul | South Korea | Recruiting |
| The Catholic University of Korea Seoul St. Mary's Hospital | Seoul | South Korea | Not Yet Recruiting |
| The Catholic University of Korea, Eunpyeong St. Mary's Hospitall | Seoul | South Korea | Recruiting |
| Seoul National University Bundang hospital | Sŏngnam | South Korea | Recruiting |
| The Catholic University of Korea, Uijeongbu St. Mary's Hospital | Uijeongbu-si | South Korea | Recruiting |
| Ulsan University Hospital | Ulsan | South Korea | Recruiting |
| Yongin Severance Hospital | Yŏngin | South Korea | Recruiting |
More Jung-min Ahn trials in South Korea
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06676280 on ClinicalTrials.gov ↗ ← All trials in South Korea